EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

OLIG2-STAT5 cooperation supports glioma stem cell maintenance and proliferation in glioblastoma

Aunay Miller iD, James McNamara, Mylan R Blomquist, David Nascari, Matthew Flick, Sidney Saladin, Serdar Tuncali, Christopher Sereduk, Keely Orndorf, Shannon P Fortin Ensign, Joseph C Loftus, Nhan L Tran iD und 1 weitere

Neuro-Oncology Advances · 12.01.2026 · 8 (1)

DOI: 10.1093/noajnl/vdag127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 12.05.2026. Verfasst von Aunay Miller und 12 weiteren Autor:innen. Beteiligte Einrichtung: Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institutes of Health, Mayo Clinic, Barrow Neurological Foundation and The Ben and Catherine Ivy Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) is driven, in part, by glioma stem cells (GSCs), which sustain therapeutic resistance and recurrence. OLIG2 is a key regulator of GSC programs but the signaling pathways that cooperate with Oligodendrocyte transcription factor 2 (OLIG2) to maintain GSC states remain incompletely defined. Although Signal transducer and activator of transcription (STAT) signaling has been implicated in GSC biology, work to date has focused primarily on STAT3, and the contribution of STAT5 remains poorly defined. Here, we investigated whether STAT5B functionally cooperates with OLIG2 in sustaining GSC phenotypes.

Methods

Transcriptomic analyses, proximity ligation assays and biochemical studies were utilized to define OLIG2-STAT5B interactions in patient-derived GSCs. Functional consequences of OLIG2, STAT5B, BIRC5, and NUSAP1 suppression were assessed using small interfering RNA/short hairpin RNA-knockdown, stemness, and migration assays in EGFRvIII-expressing GSCs. In vivo tumor growth studies were performed using orthotopic xenograft models.

Results

OLIG2 and STAT5B expression were positively correlated in GBM datasets and patient-derived models. OLIG2 physically associated with STAT5B in EGFRvIII-expressing GSCs, and loss of OLIG2 reduced STAT5 activation, supporting a functional link between these factors. OLIG2 or STAT5B suppression induced convergent transcriptional changes, including downregulation of genes associated with GSC maintenance and proliferation, notably stemness regulators BIRC5 and NUSAP1. Silencing BIRC5 or NUSAP1 impaired GSC self-renewal and migration. In orthotopic models, STAT5B knockdown prolonged survival and phenocopied OLIG2 suppression and stemness loss.

Conclusions

These findings identify STAT5B as a functional partner of OLIG2 in GBM and define anOLIG2-STAT5B transcriptional axis that sustains GSC maintenance and malignant behavior. Targeting this axis may represent a therapeutic strategy to disrupt treatment-refractory glioma cell states.

Schlagwörter

Stichwörter der Autor:innen

glioblastomaglioma stem cellstherapeutic resistancetranscriptional regulation

Autor:innen und Institutionen

  • Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, Minnesota, USA.
  • Department of Cancer Biology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Department of Neurological Surgery, Mayo Clinic Arizona, Phoenix, Arizona, USA.
  • Division of Immunology and Microbiome, Translational Genomics Research Institute, Phoenix, Arizona, USA (A.M., N.L.T.).
  • Ivy Brain Tumor Center, Barrow Neurological Institute, Phoenix, Arizona, USA.
  • Clinical Translational Sciences, University of Arizona College of Medicine Phoenix, Phoenix, AZ, USA (J.M.).

ORCID-Profile: Aunay Miller, Nhan L Tran, Shwetal Mehta

Förderung

  • National Institutes of Health
  • Mayo Clinic
  • Barrow Neurological Foundation and The Ben and Catherine Ivy Foundation
  • NIH
  • CTSA
  • National Center for Advancing Translational Science

Zitieren

APA

Miller, A., McNamara, J., Blomquist, M. R., Nascari, D., Flick, M., Saladin, S., Tuncali, S., Sereduk, C., Orndorf, K., Ensign, S. P. F., Loftus, J. C., Tran, N. L., & Mehta, S. (2026). OLIG2-STAT5 cooperation supports glioma stem cell maintenance and proliferation in glioblastoma. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag127

Vancouver

Miller A, McNamara J, Blomquist MR, Nascari D, Flick M, Saladin S, et al. OLIG2-STAT5 cooperation supports glioma stem cell maintenance and proliferation in glioblastoma. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag127

BibTeX
@article{Miller2026,
  author = {Miller, Aunay and McNamara, James and Blomquist, Mylan R and Nascari, David and Flick, Matthew and Saladin, Sidney and Tuncali, Serdar and Sereduk, Christopher and Orndorf, Keely and Ensign, Shannon P Fortin and Loftus, Joseph C and Tran, Nhan L and Mehta, Shwetal},
  title = {OLIG2-STAT5 cooperation supports glioma stem cell maintenance and proliferation in glioblastoma},
  journal = {Neuro-Oncology Advances},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1093/noajnl/vdag127}
}
Kostenlos starten →